Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Serv
InventorsJeffrey SCHLOM, Kwong-Yok TSANG
Life of this patent
Estimating the term…
Abstract
The invention provides a human cytotoxic T lymphocyte (CTL) agonist epitope from the C-terminal subunit of mucin 1 (MUC1-C), which can be used as a peptide, polypeptide (protein), and/or in vaccine or other composition for the prevention or therapy of cancer. The invention further provides a nucleic acid encoding the peptide, protein, or polypeptide, a vector comprising the nucleic acid, a cell comprising the peptide, polypeptide, nucleic acid, or vector, and compositions thereof.
Claims49
A peptide comprising the amino acid sequence of SEQ ID NO:
- 1 or SEQ ID NO:
- 2.
-8. (canceled)
The composition of claim 10, further comprising an immunostimulatory/regulatory molecule.
-19. (canceled)
(canceled)
A yeast-MUC1 immunotherapeutic composition, wherein the immunotherapeutic composition comprises:
- (a) a yeast vehicle;
- and
- (b) a fusion protein comprising at least one mucin-1 (MUC1) antigen, wherein the MUC1 antigen comprises the amino acid sequence of SEQ ID NO:
- 1 or SEQ ID NO:
- 2.
(canceled)
A yeast-MUC1 immunotherapeutic composition, wherein the immunotherapeutic composition comprises:
- (a) a yeast vehicle;
- and
- (b) a fusion protein comprising at least one MUC1 antigen, wherein the MUC1 antigen comprises an amino acid sequence that is at least 80% identical to (i) SEQ ID NO:
- 16, (ii) positions 92-566 of SEQ ID NO:
- 16, or (iii) a corresponding sequence from a different MUC1 protein, and wherein the MUC1 antigen comprises the amino acid sequence of SEQ ID NO:
- 1 or SEQ ID NO:
- 2.
-33. (canceled)
A yeast-MUC1 immunotherapeutic composition, wherein the immunotherapeutic composition comprises:
- (a) a yeast vehicle;
- and
- (b) a fusion protein comprising at least one MUC1 antigen, wherein the MUC1 antigen has an amino acid sequence that differs from an amino acid sequence of a wild-type MUC1 protein by at least one amino acid substitution at a sequence position, with respect to a wild-type MUC1 amino acid sequence, selected from:
- T422, P430, T431, 5462, and A470.
-36. (canceled)
(canceled)
-58. (canceled)
A MUC1 protein comprising the amino acid sequence of SEQ ID NO:
- 1 or SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.